Ariad Pharmaceuticals, Inc. Announces Appointment Of Hugh Cole, Senior Pharmaceutical-Industry Executive, As Chief Business Officer

Published: Apr 02, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the appointment of Hugh M. Cole to the position of senior vice president and chief business officer. Mr. Cole will be responsible for global business and corporate development, licensing and strategic planning. He will report to ARIAD’s chairman and chief executive officer, Harvey J. Berger, M.D.

Help employers find you! Check out all the jobs and post your resume.

Back to news